Integra Lifesciences Holdings (IART) Shares Outstanding (Weighted Average) (2009 - 2026)

Integra Lifesciences Holdings' Shares Outstanding (Weighted Average) history runs 18 years deep, the most recent figure standing at $77.0 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) rose 0.64% year-over-year to $77.0 million; the TTM figure through Mar 2026 stood at $77.0 million (up 0.64% YoY), while the FY2025 annual figure was $76.7 million, changed 0.44% from the prior year.
• Shares Outstanding (Weighted Average) came in at $77.0 million for Q1 2026 at Integra Lifesciences Holdings, roughly flat from $76.7 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $83.6 million in Q1 2022 to a low of $76.5 million in Q1 2025.
• A 5-year average of $79.4 million and a median of $77.7 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
• Across the five-year window, Shares Outstanding (Weighted Average) slipped 5.05% in 2024 and increased 0.64% in 2026, its largest moves.
• Integra Lifesciences Holdings' Shares Outstanding (Weighted Average) stood at $83.0 million in 2022, then fell by 3.5% to $80.1 million in 2023, then decreased by 3.84% to $77.0 million in 2024, then retreated by 0.44% to $76.7 million in 2025, then gained by 0.36% to $77.0 million in 2026.
• According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $77.0 million, $76.7 million, and $76.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison